Jena scientist receives grant for research on mitochondrial and neurodegenerative disease treatments

Dr. Kanstantsin Siniuk, postdoctoral researcher in the project group of Dr. Helmut Pospiech at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) Jena, has secured a 96,000 euro grant from the BMBF’s GO-Bio initial program for his pioneering project on mitochondrial and neurodegenerative disease treatments.

What to watch on Akero’s MASH-cirrhosis study results next month

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m suffering

January 23, 2025

Red Light Holland’s Homogenized Psilocybin Microdosing Capsules Complete Product Specification Document by cGMP Pharmaceutical Company CCrest Laboratories, Provided to NUBU Pharmaceuticals in Australasia | Psychedelic Invest

Red Light Holland’s natural psilocybin microdosing capsules developed from psilocybin truffles grown in the Company’s farm in the Netherlands, have received the final Product Specification

January 23, 2024

Sana narrows focus to ex vivo cell therapies, lays off 29% of staff to reach key clinical data

Sana Biotechnology will let go about 29% of its staff, or roughly 120 employees, to focus on its ex vivo cell therapies, according to a

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.